UniProt ID | MBB1A_HUMAN | |
---|---|---|
UniProt AC | Q9BQG0 | |
Protein Name | Myb-binding protein 1A | |
Gene Name | MYBBP1A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1328 | |
Subcellular Localization | Cytoplasm . Nucleus . Nucleus, nucleolus . Shuttles between the nucleus and cytoplasm. Nuclear import may be mediated by KPNA2, while export appears to depend partially on XPO1/CRM1 (By similarity). Predominantly nucleolar. | |
Protein Description | May activate or repress transcription via interactions with sequence specific DNA-binding proteins. Repression may be mediated at least in part by histone deacetylase activity (HDAC activity). Acts as a corepressor and in concert with CRY1, represses the transcription of the core circadian clock component PER2. Preferentially binds to dimethylated histone H3 'Lys-9' (H3K9me2) on the PER2 promoter.. | |
Protein Sequence | MESRDPAQPMSPGEATQSGARPADRYGLLKHSREFLDFFWDIAKPEQETRLAATEKLLEYLRGRPKGSEMKYALKRLITGLGVGRETARPCYSLALAQLLQSFEDLPLCSILQQIQEKYDLHQVKKAMLRPALFANLFGVLALFQSGRLVKDQEALMKSVKLLQALAQYQNHLQEQPRKALVDILSEVSKATLQEILPEVLKADLNIILSSPEQLELFLLAQQKVPSKLKKLVGSVNLFSDENVPRLVNVLKMAASSVKKDRKLPAIALDLLRLALKEDKFPRFWKEVVEQGLLKMQFWPASYLCFRLLGAALPLLTKEQLHLVMQGDVIRHYGEHVCTAKLPKQFKFAPEMDDYVGTFLEGCQDDPERQLAVLVAFSSVTNQGLPVTPTFWRVVRFLSPPALQGYVAWLRAMFLQPDLDSLVDFSTNNQKKAQDSSLHMPERAVFRLRKWIIFRLVSIVDSLHLEMEEALTEQVARFCLFHSFFVTKKPTSQIPETKHPFSFPLENQAREAVSSAFFSLLQTLSTQFKQAPGQTQGGQPWTYHLVQFADLLLNHSHNVTTVTPFTAQQRQAWDRMLQTLKELEAHSAEARAAAFQHLLLLVGIHLLKSPAESCDLLGDIQTCIRKSLGEKPRRSRTKTIDPQEPPWVEVLVEILLALLAQPSHLMRQVARSVFGHICSHLTPRALQLILDVLNPETSEDENDRVVVTDDSDERRLKGAEDKSEEGEDNRSSESEEESEGEESEEEERDGDVDQGFREQLMTVLQAGKALGGEDSENEEELGDEAMMALDQSLASLFAEQKLRIQARRDEKNKLQKEKALRRDFQIRVLDLVEVLVTKQPENALVLELLEPLLSIIRRSLRSSSSKQEQDLLHKTARIFTHHLCRARRYCHDLGERAGALHAQVERLVQQAGRQPDSPTALYHFNASLYLLRVLKGNTAEGCVHETQEKQKAGTDPSHMPTGPQAASCLDLNLVTRVYSTALSSFLTKRNSPLTVPMFLSLFSRHPVLCQSLLPILVQHITGPVRPRHQACLLLQKTLSMREVRSCFEDPEWKQLMGQVLAKVTENLRVLGEAQTKAQHQQALSSLELLNVLFRTCKHEKLTLDLTVLLGVLQGQQQSLQQGAHSTGSSRLHDLYWQAMKTLGVQRPKLEKKDAKEIPSATQSPISKKRKKKGFLPETKKRKKRKSEDGTPAEDGTPAATGGSQPPSMGRKKRNRTKAKVPAQANGTPTTKSPAPGAPTRSPSTPAKSPKLQKKNQKPSQVNGAPGSPTEPAGQKQHQKALPKKGVLGKSPLSALARKKARLSLVIRSPSLLQSGAKKKAQVRKAGKP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MESRDPAQ -------CCCCCCCC | 44.98 | - | |
3 | Phosphorylation | -----MESRDPAQPM -----CCCCCCCCCC | 54.57 | 26074081 | |
10 | Sulfoxidation | SRDPAQPMSPGEATQ CCCCCCCCCCCCCCC | 5.12 | 21406390 | |
11 | Phosphorylation | RDPAQPMSPGEATQS CCCCCCCCCCCCCCC | 36.11 | 19664994 | |
11 (in isoform 2) | Phosphorylation | - | 36.11 | 24719451 | |
16 | Phosphorylation | PMSPGEATQSGARPA CCCCCCCCCCCCCCH | 20.97 | 23927012 | |
16 (in isoform 2) | Phosphorylation | - | 20.97 | 21406692 | |
18 | Phosphorylation | SPGEATQSGARPADR CCCCCCCCCCCCHHH | 30.02 | 25159151 | |
18 (in isoform 2) | Phosphorylation | - | 30.02 | 21406692 | |
26 | Phosphorylation | GARPADRYGLLKHSR CCCCHHHHHCHHHHH | 16.81 | 24732914 | |
30 | Acetylation | ADRYGLLKHSREFLD HHHHHCHHHHHHHHH | 44.57 | 26051181 | |
30 | Methylation | ADRYGLLKHSREFLD HHHHHCHHHHHHHHH | 44.57 | 115973417 | |
30 | Ubiquitination | ADRYGLLKHSREFLD HHHHHCHHHHHHHHH | 44.57 | 29967540 | |
30 (in isoform 2) | Ubiquitination | - | 44.57 | - | |
32 | Phosphorylation | RYGLLKHSREFLDFF HHHCHHHHHHHHHHH | 31.73 | 26074081 | |
44 | Ubiquitination | DFFWDIAKPEQETRL HHHHHHCCHHHHHHH | 49.80 | - | |
49 | Phosphorylation | IAKPEQETRLAATEK HCCHHHHHHHHHHHH | 30.58 | 21406692 | |
54 | Phosphorylation | QETRLAATEKLLEYL HHHHHHHHHHHHHHH | 28.22 | 21406692 | |
56 | Acetylation | TRLAATEKLLEYLRG HHHHHHHHHHHHHCC | 54.76 | 25953088 | |
56 | Ubiquitination | TRLAATEKLLEYLRG HHHHHHHHHHHHHCC | 54.76 | 21963094 | |
56 (in isoform 1) | Ubiquitination | - | 54.76 | 21890473 | |
56 (in isoform 2) | Ubiquitination | - | 54.76 | 21890473 | |
60 | Phosphorylation | ATEKLLEYLRGRPKG HHHHHHHHHCCCCCC | 11.15 | 17081983 | |
71 | Acetylation | RPKGSEMKYALKRLI CCCCHHHHHHHHHHH | 24.26 | 19608861 | |
71 | Ubiquitination | RPKGSEMKYALKRLI CCCCHHHHHHHHHHH | 24.26 | 29967540 | |
71 (in isoform 2) | Ubiquitination | - | 24.26 | - | |
79 | Phosphorylation | YALKRLITGLGVGRE HHHHHHHHHCCCCHH | 30.83 | - | |
93 | O-linked_Glycosylation | ETARPCYSLALAQLL HHHHHHHHHHHHHHH | 17.55 | 29351928 | |
95 | Ubiquitination | ARPCYSLALAQLLQS HHHHHHHHHHHHHHH | 8.56 | 21963094 | |
102 | O-linked_Glycosylation | ALAQLLQSFEDLPLC HHHHHHHHCCCCCHH | 30.49 | 29351928 | |
125 | Acetylation | KYDLHQVKKAMLRPA HCCHHHHHHHHHHHH | 28.39 | 26051181 | |
125 | Ubiquitination | KYDLHQVKKAMLRPA HCCHHHHHHHHHHHH | 28.39 | 33845483 | |
128 | Sulfoxidation | LHQVKKAMLRPALFA HHHHHHHHHHHHHHH | 4.47 | 28183972 | |
151 | Ubiquitination | FQSGRLVKDQEALMK HHCCCCCCCHHHHHH | 59.28 | - | |
151 (in isoform 2) | Ubiquitination | - | 59.28 | - | |
157 | Sulfoxidation | VKDQEALMKSVKLLQ CCCHHHHHHHHHHHH | 3.81 | 21406390 | |
158 | Acetylation | KDQEALMKSVKLLQA CCHHHHHHHHHHHHH | 53.61 | 19608861 | |
158 | Malonylation | KDQEALMKSVKLLQA CCHHHHHHHHHHHHH | 53.61 | 26320211 | |
158 | Ubiquitination | KDQEALMKSVKLLQA CCHHHHHHHHHHHHH | 53.61 | 22817900 | |
161 | Ubiquitination | EALMKSVKLLQALAQ HHHHHHHHHHHHHHH | 51.04 | 21890473 | |
161 (in isoform 1) | Ubiquitination | - | 51.04 | 21890473 | |
161 (in isoform 2) | Ubiquitination | - | 51.04 | 21890473 | |
169 | Phosphorylation | LLQALAQYQNHLQEQ HHHHHHHHHHHHHHC | 12.99 | 28152594 | |
179 | Acetylation | HLQEQPRKALVDILS HHHHCHHHHHHHHHH | 53.40 | 26051181 | |
179 | Ubiquitination | HLQEQPRKALVDILS HHHHCHHHHHHHHHH | 53.40 | 22817900 | |
179 (in isoform 1) | Ubiquitination | - | 53.40 | 21890473 | |
179 (in isoform 2) | Ubiquitination | - | 53.40 | 21890473 | |
186 | Phosphorylation | KALVDILSEVSKATL HHHHHHHHHHCHHHH | 35.96 | - | |
189 | Phosphorylation | VDILSEVSKATLQEI HHHHHHHCHHHHHHH | 16.72 | 20071362 | |
228 | Ubiquitination | AQQKVPSKLKKLVGS HHCCCCHHHHHHHCC | 59.25 | 22817900 | |
230 | Ubiquitination | QKVPSKLKKLVGSVN CCCCHHHHHHHCCCC | 48.04 | 22817900 | |
231 | Malonylation | KVPSKLKKLVGSVNL CCCHHHHHHHCCCCC | 59.86 | 26320211 | |
231 | Ubiquitination | KVPSKLKKLVGSVNL CCCHHHHHHHCCCCC | 59.86 | 22817900 | |
231 (in isoform 1) | Ubiquitination | - | 59.86 | 21890473 | |
231 (in isoform 2) | Ubiquitination | - | 59.86 | 21890473 | |
252 | Acetylation | PRLVNVLKMAASSVK HHHHHHHHHHHHHCC | 23.39 | 25953088 | |
252 | Ubiquitination | PRLVNVLKMAASSVK HHHHHHHHHHHHHCC | 23.39 | 24816145 | |
259 | Acetylation | KMAASSVKKDRKLPA HHHHHHCCCCCCCCH | 51.40 | 25953088 | |
277 | Ubiquitination | DLLRLALKEDKFPRF HHHHHHHHCCCCHHH | 59.25 | - | |
286 | Acetylation | DKFPRFWKEVVEQGL CCCHHHHHHHHHHCC | 37.61 | 26051181 | |
302 | Phosphorylation | KMQFWPASYLCFRLL HHCCCCHHHHHHHHH | 17.98 | 20068231 | |
303 | Phosphorylation | MQFWPASYLCFRLLG HCCCCHHHHHHHHHH | 15.03 | 20068231 | |
329 | Ubiquitination | HLVMQGDVIRHYGEH HHHHCCCHHHHHCCC | 5.46 | 24816145 | |
333 | Phosphorylation | QGDVIRHYGEHVCTA CCCHHHHHCCCEEEC | 17.85 | 28152594 | |
341 | Acetylation | GEHVCTAKLPKQFKF CCCEEECCCCCCCCC | 47.36 | 25953088 | |
341 | Ubiquitination | GEHVCTAKLPKQFKF CCCEEECCCCCCCCC | 47.36 | 32015554 | |
341 (in isoform 2) | Ubiquitination | - | 47.36 | - | |
347 | Ubiquitination | AKLPKQFKFAPEMDD CCCCCCCCCCCCCCC | 37.82 | 21963094 | |
363 | Glutathionylation | VGTFLEGCQDDPERQ HHHHHHHCCCCHHHH | 2.68 | 22555962 | |
374 | Ubiquitination | PERQLAVLVAFSSVT HHHHHHHHHHHHHHC | 1.59 | 24816145 | |
399 | Phosphorylation | WRVVRFLSPPALQGY HHHHHHHCCHHHHHH | 26.56 | - | |
413 | Sulfoxidation | YVAWLRAMFLQPDLD HHHHHHHHHHCCCHH | 2.52 | 28183972 | |
421 | Phosphorylation | FLQPDLDSLVDFSTN HHCCCHHHHCCCCCC | 37.27 | 20873877 | |
426 | O-linked_Glycosylation | LDSLVDFSTNNQKKA HHHHCCCCCCCHHHH | 26.26 | 29351928 | |
426 | Phosphorylation | LDSLVDFSTNNQKKA HHHHCCCCCCCHHHH | 26.26 | 20873877 | |
427 | O-linked_Glycosylation | DSLVDFSTNNQKKAQ HHHCCCCCCCHHHHC | 37.88 | 29351928 | |
432 | Ubiquitination | FSTNNQKKAQDSSLH CCCCCHHHHCCCCCC | 41.33 | - | |
432 (in isoform 2) | Ubiquitination | - | 41.33 | - | |
450 | Acetylation | RAVFRLRKWIIFRLV HHHHHHHHHHHHHHH | 47.54 | 26051181 | |
487 | Phosphorylation | LFHSFFVTKKPTSQI HHHHHHCCCCCCCCC | 28.35 | - | |
488 | Acetylation | FHSFFVTKKPTSQIP HHHHHCCCCCCCCCC | 51.99 | 26051181 | |
489 | Acetylation | HSFFVTKKPTSQIPE HHHHCCCCCCCCCCC | 44.13 | 26051181 | |
491 | Phosphorylation | FFVTKKPTSQIPETK HHCCCCCCCCCCCCC | 41.99 | 25850435 | |
492 | Phosphorylation | FVTKKPTSQIPETKH HCCCCCCCCCCCCCC | 34.34 | 25849741 | |
497 | Phosphorylation | PTSQIPETKHPFSFP CCCCCCCCCCCCCCC | 29.33 | 25850435 | |
498 | Acetylation | TSQIPETKHPFSFPL CCCCCCCCCCCCCCC | 47.85 | 25953088 | |
498 | Ubiquitination | TSQIPETKHPFSFPL CCCCCCCCCCCCCCC | 47.85 | - | |
502 | Phosphorylation | PETKHPFSFPLENQA CCCCCCCCCCCCHHH | 30.33 | 23312004 | |
514 | Phosphorylation | NQAREAVSSAFFSLL HHHHHHHHHHHHHHH | 24.01 | 21601212 | |
523 | Phosphorylation | AFFSLLQTLSTQFKQ HHHHHHHHHHHHHHC | 23.73 | 21601212 | |
561 | Ubiquitination | NHSHNVTTVTPFTAQ HCCCCCCEECCCCHH | 20.35 | 24816145 | |
581 | Acetylation | DRMLQTLKELEAHSA HHHHHHHHHHHHCCH | 64.74 | 26051181 | |
581 | Ubiquitination | DRMLQTLKELEAHSA HHHHHHHHHHHHCCH | 64.74 | 24816145 | |
581 (in isoform 1) | Ubiquitination | - | 64.74 | 21890473 | |
581 (in isoform 2) | Ubiquitination | - | 64.74 | 21890473 | |
591 | Methylation | EAHSAEARAAAFQHL HHCCHHHHHHHHHHH | 19.10 | 115388349 | |
613 | Phosphorylation | LLKSPAESCDLLGDI HHCCHHHHCCHHHHH | 18.29 | 25159151 | |
614 | Ubiquitination | LKSPAESCDLLGDIQ HCCHHHHCCHHHHHH | 3.00 | 24816145 | |
626 | Ubiquitination | DIQTCIRKSLGEKPR HHHHHHHHHCCCCCC | 30.07 | 24816145 | |
631 | Acetylation | IRKSLGEKPRRSRTK HHHHCCCCCCCCCCC | 41.86 | 23749302 | |
631 | Ubiquitination | IRKSLGEKPRRSRTK HHHHCCCCCCCCCCC | 41.86 | 29967540 | |
635 | Phosphorylation | LGEKPRRSRTKTIDP CCCCCCCCCCCCCCC | 45.65 | 17081983 | |
637 | Phosphorylation | EKPRRSRTKTIDPQE CCCCCCCCCCCCCCC | 33.51 | 29759185 | |
663 | Phosphorylation | LALLAQPSHLMRQVA HHHHCCHHHHHHHHH | 19.71 | - | |
672 | Phosphorylation | LMRQVARSVFGHICS HHHHHHHHHHHHHHH | 16.44 | 20873877 | |
683 | Ubiquitination | HICSHLTPRALQLIL HHHHCCCHHHHHHHH | 26.38 | 21963094 | |
697 | Phosphorylation | LDVLNPETSEDENDR HHHHCCCCCCCCCCC | 38.38 | 29116813 | |
698 | Phosphorylation | DVLNPETSEDENDRV HHHCCCCCCCCCCCE | 41.19 | 20873877 | |
708 | Phosphorylation | ENDRVVVTDDSDERR CCCCEEECCCHHHHH | 23.60 | 21815630 | |
711 | Phosphorylation | RVVVTDDSDERRLKG CEEECCCHHHHHHCC | 44.15 | 25849741 | |
723 | Phosphorylation | LKGAEDKSEEGEDNR HCCCCCCCCCCCCCC | 53.88 | 25137130 | |
731 | Phosphorylation | EEGEDNRSSESEEES CCCCCCCCCCCCCHH | 44.72 | 25137130 | |
732 | Phosphorylation | EGEDNRSSESEEESE CCCCCCCCCCCCHHC | 41.74 | 25137130 | |
734 | Phosphorylation | EDNRSSESEEESEGE CCCCCCCCCCHHCCC | 52.86 | 25137130 | |
736 | Ubiquitination | NRSSESEEESEGEES CCCCCCCCHHCCCCC | 75.90 | 21890473 | |
738 | Phosphorylation | SSESEEESEGEESEE CCCCCCHHCCCCCHH | 54.93 | 25137130 | |
743 | Phosphorylation | EESEGEESEEEERDG CHHCCCCCHHHHHCC | 46.11 | 25137130 | |
761 | Sulfoxidation | QGFREQLMTVLQAGK HHHHHHHHHHHHHHH | 2.14 | 21406390 | |
775 | Phosphorylation | KALGGEDSENEEELG HHHCCCCCCCHHHHH | 37.71 | 25159151 | |
775 (in isoform 2) | Phosphorylation | - | 37.71 | 24719451 | |
784 | Ubiquitination | NEEELGDEAMMALDQ CHHHHHHHHHHHHHH | 36.34 | 21890473 | |
792 | Phosphorylation | AMMALDQSLASLFAE HHHHHHHHHHHHHHH | 26.10 | 25159151 | |
795 | Phosphorylation | ALDQSLASLFAEQKL HHHHHHHHHHHHHHH | 29.34 | 30175587 | |
813 | Ubiquitination | ARRDEKNKLQKEKAL HHHHHHHHHHHHHHH | 64.46 | 24816145 | |
859 | Phosphorylation | LLSIIRRSLRSSSSK HHHHHHHHHHCCCCH | 20.48 | - | |
862 | Phosphorylation | IIRRSLRSSSSKQEQ HHHHHHHCCCCHHHH | 39.61 | 20873877 | |
863 | Phosphorylation | IRRSLRSSSSKQEQD HHHHHHCCCCHHHHH | 32.00 | 20873877 | |
864 | Phosphorylation | RRSLRSSSSKQEQDL HHHHHCCCCHHHHHH | 42.68 | 20873877 | |
865 | Phosphorylation | RSLRSSSSKQEQDLL HHHHCCCCHHHHHHH | 40.06 | 22210691 | |
866 | Ubiquitination | SLRSSSSKQEQDLLH HHHCCCCHHHHHHHH | 60.86 | 24816145 | |
866 (in isoform 2) | Ubiquitination | - | 60.86 | - | |
874 | Ubiquitination | QEQDLLHKTARIFTH HHHHHHHHHHHHHHH | 43.80 | - | |
874 (in isoform 2) | Ubiquitination | - | 43.80 | - | |
888 | Ubiquitination | HHLCRARRYCHDLGE HHHHHHHHHHHHHHH | 37.13 | 21890473 | |
889 | Phosphorylation | HLCRARRYCHDLGER HHHHHHHHHHHHHHH | 6.65 | 28152594 | |
896 | Methylation | YCHDLGERAGALHAQ HHHHHHHHHCHHHHH | 36.20 | 115484091 | |
920 | Ubiquitination | RQPDSPTALYHFNAS CCCCCCCHHHHHHHH | 14.98 | 24816145 | |
933 | Ubiquitination | ASLYLLRVLKGNTAE HHHHHHHHHCCCCCC | 6.99 | 24816145 | |
935 | Acetylation | LYLLRVLKGNTAEGC HHHHHHHCCCCCCCC | 47.46 | 26822725 | |
935 | Ubiquitination | LYLLRVLKGNTAEGC HHHHHHHCCCCCCCC | 47.46 | 21963094 | |
935 (in isoform 2) | Ubiquitination | - | 47.46 | - | |
942 | Glutathionylation | KGNTAEGCVHETQEK CCCCCCCCCCCHHHH | 1.81 | 22555962 | |
946 | Phosphorylation | AEGCVHETQEKQKAG CCCCCCCHHHHHHCC | 27.44 | 25159151 | |
949 | Acetylation | CVHETQEKQKAGTDP CCCCHHHHHHCCCCC | 47.48 | 26051181 | |
949 | Ubiquitination | CVHETQEKQKAGTDP CCCCHHHHHHCCCCC | 47.48 | 29967540 | |
967 | Ubiquitination | PTGPQAASCLDLNLV CCCHHHHHHHCHHHH | 20.44 | 24816145 | |
968 | Glutathionylation | TGPQAASCLDLNLVT CCHHHHHHHCHHHHH | 2.69 | 22555962 | |
978 | Phosphorylation | LNLVTRVYSTALSSF HHHHHHHHHHHHHHH | 9.30 | 24719451 | |
978 (in isoform 2) | Phosphorylation | - | 9.30 | 24719451 | |
979 | Phosphorylation | NLVTRVYSTALSSFL HHHHHHHHHHHHHHH | 12.35 | 28152594 | |
980 | Phosphorylation | LVTRVYSTALSSFLT HHHHHHHHHHHHHHH | 17.58 | 24719451 | |
980 (in isoform 2) | Phosphorylation | - | 17.58 | 24719451 | |
983 | Phosphorylation | RVYSTALSSFLTKRN HHHHHHHHHHHHHCC | 19.31 | 20860994 | |
984 | Phosphorylation | VYSTALSSFLTKRNS HHHHHHHHHHHHCCC | 25.73 | 21406692 | |
987 | Phosphorylation | TALSSFLTKRNSPLT HHHHHHHHHCCCCCH | 26.41 | 20860994 | |
987 (in isoform 2) | Phosphorylation | - | 26.41 | 21406692 | |
988 | Acetylation | ALSSFLTKRNSPLTV HHHHHHHHCCCCCHH | 52.29 | 25953088 | |
988 | Ubiquitination | ALSSFLTKRNSPLTV HHHHHHHHCCCCCHH | 52.29 | 21890473 | |
988 (in isoform 1) | Ubiquitination | - | 52.29 | 21890473 | |
988 (in isoform 2) | Ubiquitination | - | 52.29 | 21890473 | |
991 | Phosphorylation | SFLTKRNSPLTVPMF HHHHHCCCCCHHHHH | 25.89 | 27461979 | |
994 | Phosphorylation | TKRNSPLTVPMFLSL HHCCCCCHHHHHHHH | 26.41 | 27461979 | |
994 (in isoform 2) | Phosphorylation | - | 26.41 | 24719451 | |
1000 | Phosphorylation | LTVPMFLSLFSRHPV CHHHHHHHHHHCCHH | 18.99 | 27461979 | |
1003 | Phosphorylation | PMFLSLFSRHPVLCQ HHHHHHHHCCHHHHH | 34.67 | 27461979 | |
1011 | Phosphorylation | RHPVLCQSLLPILVQ CCHHHHHHHHHHHHH | 30.77 | - | |
1021 | Phosphorylation | PILVQHITGPVRPRH HHHHHHCCCCCCHHH | 33.05 | - | |
1031 | S-nitrosocysteine | VRPRHQACLLLQKTL CCHHHHHHHHHHHHC | 1.90 | - | |
1031 | S-nitrosylation | VRPRHQACLLLQKTL CCHHHHHHHHHHHHC | 1.90 | 19483679 | |
1036 | Acetylation | QACLLLQKTLSMREV HHHHHHHHHCCHHHH | 51.94 | 26051181 | |
1036 | Ubiquitination | QACLLLQKTLSMREV HHHHHHHHHCCHHHH | 51.94 | 21890473 | |
1036 (in isoform 1) | Ubiquitination | - | 51.94 | 21890473 | |
1036 (in isoform 2) | Ubiquitination | - | 51.94 | 21890473 | |
1046 | Glutathionylation | SMREVRSCFEDPEWK CHHHHHHHCCCHHHH | 2.80 | 22555962 | |
1053 | Acetylation | CFEDPEWKQLMGQVL HCCCHHHHHHHHHHH | 31.71 | 26051181 | |
1053 | Ubiquitination | CFEDPEWKQLMGQVL HCCCHHHHHHHHHHH | 31.71 | 29967540 | |
1062 | Acetylation | LMGQVLAKVTENLRV HHHHHHHHHHHHHHH | 45.59 | 26051181 | |
1062 | Ubiquitination | LMGQVLAKVTENLRV HHHHHHHHHHHHHHH | 45.59 | - | |
1062 (in isoform 2) | Ubiquitination | - | 45.59 | - | |
1067 | Ubiquitination | LAKVTENLRVLGEAQ HHHHHHHHHHHHHHH | 3.05 | 24816145 | |
1139 | Sulfoxidation | HDLYWQAMKTLGVQR HHHHHHHHHHHCCCC | 1.72 | 28183972 | |
1140 | Acetylation | DLYWQAMKTLGVQRP HHHHHHHHHHCCCCC | 43.55 | 26051181 | |
1140 | Ubiquitination | DLYWQAMKTLGVQRP HHHHHHHHHHCCCCC | 43.55 | 22817900 | |
1140 (in isoform 1) | Ubiquitination | - | 43.55 | 21890473 | |
1140 (in isoform 2) | Ubiquitination | - | 43.55 | 21890473 | |
1148 | Sumoylation | TLGVQRPKLEKKDAK HHCCCCCCCCCCCHH | 72.04 | 28112733 | |
1148 | Ubiquitination | TLGVQRPKLEKKDAK HHCCCCCCCCCCCHH | 72.04 | 29967540 | |
1155 | Acetylation | KLEKKDAKEIPSATQ CCCCCCHHHCCCCCC | 67.33 | 26051181 | |
1155 | Ubiquitination | KLEKKDAKEIPSATQ CCCCCCHHHCCCCCC | 67.33 | 29967540 | |
1159 | Phosphorylation | KDAKEIPSATQSPIS CCHHHCCCCCCCCCC | 50.00 | 29255136 | |
1159 (in isoform 2) | Phosphorylation | - | 50.00 | 24719451 | |
1161 | Phosphorylation | AKEIPSATQSPISKK HHHCCCCCCCCCCHH | 33.64 | 29255136 | |
1161 (in isoform 2) | Phosphorylation | - | 33.64 | 21406692 | |
1163 | Phosphorylation | EIPSATQSPISKKRK HCCCCCCCCCCHHHH | 21.61 | 19664994 | |
1163 (in isoform 2) | Phosphorylation | - | 21.61 | 24719451 | |
1166 | Phosphorylation | SATQSPISKKRKKKG CCCCCCCCHHHHHCC | 35.19 | 29255136 | |
1167 | Acetylation | ATQSPISKKRKKKGF CCCCCCCHHHHHCCC | 58.27 | 25953088 | |
1172 | Ubiquitination | ISKKRKKKGFLPETK CCHHHHHCCCCCHHH | 58.91 | 24816145 | |
1178 | Phosphorylation | KKGFLPETKKRKKRK HCCCCCHHHHCCCCC | 39.67 | 24173317 | |
1179 | Acetylation | KGFLPETKKRKKRKS CCCCCHHHHCCCCCC | 49.25 | 25953088 | |
1185 | Acetylation | TKKRKKRKSEDGTPA HHHCCCCCCCCCCCC | 68.05 | 26051181 | |
1185 | Ubiquitination | TKKRKKRKSEDGTPA HHHCCCCCCCCCCCC | 68.05 | 24816145 | |
1186 | Phosphorylation | KKRKKRKSEDGTPAE HHCCCCCCCCCCCCC | 44.98 | 30266825 | |
1186 (in isoform 2) | Phosphorylation | - | 44.98 | 24719451 | |
1190 | Phosphorylation | KRKSEDGTPAEDGTP CCCCCCCCCCCCCCC | 31.48 | 30266825 | |
1196 | Phosphorylation | GTPAEDGTPAATGGS CCCCCCCCCCCCCCC | 23.29 | 30266825 | |
1196 (in isoform 2) | Phosphorylation | - | 23.29 | 27251275 | |
1200 | Phosphorylation | EDGTPAATGGSQPPS CCCCCCCCCCCCCCC | 44.15 | 23927012 | |
1203 | Phosphorylation | TPAATGGSQPPSMGR CCCCCCCCCCCCCCC | 40.64 | 23927012 | |
1207 | Phosphorylation | TGGSQPPSMGRKKRN CCCCCCCCCCCCCCC | 40.32 | 23927012 | |
1208 | Sulfoxidation | GGSQPPSMGRKKRNR CCCCCCCCCCCCCCC | 8.10 | 21406390 | |
1219 | Acetylation | KRNRTKAKVPAQANG CCCCCCCCCCCCCCC | 50.75 | 25953088 | |
1219 | Ubiquitination | KRNRTKAKVPAQANG CCCCCCCCCCCCCCC | 50.75 | 24816145 | |
1227 | Phosphorylation | VPAQANGTPTTKSPA CCCCCCCCCCCCCCC | 19.78 | 30266825 | |
1227 (in isoform 2) | Phosphorylation | - | 19.78 | 27251275 | |
1229 | Phosphorylation | AQANGTPTTKSPAPG CCCCCCCCCCCCCCC | 46.85 | 30266825 | |
1230 | Phosphorylation | QANGTPTTKSPAPGA CCCCCCCCCCCCCCC | 30.63 | 30266825 | |
1231 | Acetylation | ANGTPTTKSPAPGAP CCCCCCCCCCCCCCC | 57.85 | 25953088 | |
1232 | Phosphorylation | NGTPTTKSPAPGAPT CCCCCCCCCCCCCCC | 24.97 | 30266825 | |
1232 (in isoform 2) | Phosphorylation | - | 24.97 | 21406692 | |
1239 | Phosphorylation | SPAPGAPTRSPSTPA CCCCCCCCCCCCCCC | 43.15 | 23927012 | |
1239 (in isoform 2) | Phosphorylation | - | 43.15 | 21406692 | |
1241 | Phosphorylation | APGAPTRSPSTPAKS CCCCCCCCCCCCCCC | 26.19 | 25159151 | |
1241 (in isoform 2) | Phosphorylation | - | 26.19 | 24719451 | |
1243 | Phosphorylation | GAPTRSPSTPAKSPK CCCCCCCCCCCCCHH | 48.55 | 30266825 | |
1244 | Phosphorylation | APTRSPSTPAKSPKL CCCCCCCCCCCCHHH | 30.56 | 30266825 | |
1244 (in isoform 2) | Phosphorylation | - | 30.56 | 24719451 | |
1247 | Acetylation | RSPSTPAKSPKLQKK CCCCCCCCCHHHHHC | 69.37 | 25953088 | |
1248 | Phosphorylation | SPSTPAKSPKLQKKN CCCCCCCCHHHHHCC | 29.40 | 25159151 | |
1259 | Phosphorylation | QKKNQKPSQVNGAPG HHCCCCCCCCCCCCC | 54.52 | 29255136 | |
1267 | Phosphorylation | QVNGAPGSPTEPAGQ CCCCCCCCCCCCCCH | 27.82 | 19664994 | |
1267 (in isoform 2) | Phosphorylation | - | 27.82 | 24719451 | |
1269 | Phosphorylation | NGAPGSPTEPAGQKQ CCCCCCCCCCCCHHH | 57.19 | 22167270 | |
1269 (in isoform 2) | Phosphorylation | - | 57.19 | 21406692 | |
1284 | Acetylation | HQKALPKKGVLGKSP HHHHCCCCCCCCCCH | 52.92 | 25953088 | |
1289 | Acetylation | PKKGVLGKSPLSALA CCCCCCCCCHHHHHH | 44.75 | 25953088 | |
1290 | Phosphorylation | KKGVLGKSPLSALAR CCCCCCCCHHHHHHH | 29.31 | 29255136 | |
1290 (in isoform 2) | Phosphorylation | - | 29.31 | 24719451 | |
1293 | Phosphorylation | VLGKSPLSALARKKA CCCCCHHHHHHHHHH | 25.31 | 23927012 | |
1293 (in isoform 2) | Phosphorylation | - | 25.31 | 24719451 | |
1303 | Phosphorylation | ARKKARLSLVIRSPS HHHHHHHHHHHCCHH | 18.29 | 25159151 | |
1303 (in isoform 2) | Phosphorylation | - | 18.29 | 24719451 | |
1307 | Citrullination | ARLSLVIRSPSLLQS HHHHHHHCCHHHHHC | 34.73 | - | |
1307 | Citrullination | ARLSLVIRSPSLLQS HHHHHHHCCHHHHHC | 34.73 | - | |
1308 | O-linked_Glycosylation | RLSLVIRSPSLLQSG HHHHHHCCHHHHHCC | 14.02 | 29351928 | |
1308 | Phosphorylation | RLSLVIRSPSLLQSG HHHHHHCCHHHHHCC | 14.02 | 29255136 | |
1308 (in isoform 2) | Phosphorylation | - | 14.02 | 29743597 | |
1310 | Phosphorylation | SLVIRSPSLLQSGAK HHHHCCHHHHHCCHH | 42.85 | 29255136 | |
1310 (in isoform 2) | Phosphorylation | - | 42.85 | 24719451 | |
1314 | Phosphorylation | RSPSLLQSGAKKKAQ CCHHHHHCCHHHHHH | 40.46 | 25159151 | |
1314 (in isoform 2) | Phosphorylation | - | 40.46 | 29743597 | |
1317 | Acetylation | SLLQSGAKKKAQVRK HHHHCCHHHHHHHHH | 59.33 | 25953088 | |
1319 | Acetylation | LQSGAKKKAQVRKAG HHCCHHHHHHHHHCC | 43.26 | 19824341 | |
1319 | Ubiquitination | LQSGAKKKAQVRKAG HHCCHHHHHHHHHCC | 43.26 | 24816145 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MBB1A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MBB1A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-711; SER-775;SER-1163; THR-1227; SER-1232; SER-1290; SER-1308; SER-1310 ANDSER-1314, ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASSSPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-71 AND LYS-158, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775; SER-1163; SER-1267AND SER-1310, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1159; THR-1161;SER-1163; THR-1196; SER-1207; THR-1227; SER-1267 AND THR-1269, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-775; SER-1159;SER-1163; SER-1186; THR-1190; THR-1196; SER-1207; SER-1241; THR-1244;SER-1248; SER-1267; SER-1290; SER-1293; SER-1303; SER-1308 ANDSER-1314, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-775; SER-1159;THR-1161; SER-1163; THR-1227; SER-1267 AND SER-1290, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1186 AND THR-1190, ANDMASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1163 AND SER-1166, ANDMASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-711; SER-775;SER-1163; THR-1227; SER-1232; SER-1290; SER-1308; SER-1310 ANDSER-1314, ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1290; SER-1293; SER-1308AND SER-1314, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775; SER-1163 ANDSER-1267, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-1159; SER-1163;SER-1290; SER-1308 AND SER-1314, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; TYR-60; SER-775 ANDSER-1267, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1163, AND MASSSPECTROMETRY. |